CtDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation

ABSTRACT: In this study, the investigators aimed to apply their previously developed multi-locus blood-based assay targeting circulating tumor DNA methylation to monitor postoperative relapse and evaluate adjuvant chemotherapy efficacy in resected stage I and stage II (without high risk) colorectal cancer after radical resection.

DISEASE(S): Cancer Colorectal

PROVIDER: 2747987 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR